Corcept Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Corcept Therapeutics stock have an average target of 105.2, with a low estimate of 60 and a high estimate of 150. The average target predicts an increase of 194.76% from the current stock price of 35.69.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$60	$105.2	$100	$150
Change	+68.11%	+194.76%	+180.19%	+320.29%

Analyst Ratings

The average analyst rating for Corcept Therapeutics stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	3	3	3	3	3	3
Buy	1	1	1	1	1	1
Hold	0	1	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	5	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $67 → $60	Strong Buy	Maintains	$67 → $60	+68.11%	Feb 25, 2026
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $105 → $67	Strong Buy	Maintains	$105 → $67	+87.73%	Feb 20, 2026
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $99 → $100	Strong Buy	Maintains	$99 → $100	+180.19%	Jan 23, 2026
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $90 → $105	Strong Buy	Maintains	$90 → $105	+194.20%	Jan 23, 2026
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $140 → $99	Strong Buy	Maintains	$140 → $99	+177.39%	Jan 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

994.62M

from 761.41M

30.63%

from 761.41M

Revenue Next Year

1.31B

from 994.62M

31.61%

from 994.62M

EPS This Year

0.62

from 0.82

-24.54%

from 0.82

EPS Next Year

3.14

from 0.62

406.87%

from 0.62

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	365.98M	401.86M	482.38M	675.04M	761.41M	994.62M	1.31B
Revenue Growth	3.42%	9.80%	20.04%	39.94%	12.79%	30.63%	31.61%
EPS	0.89	0.87	0.94	1.23	0.82	0.62	3.14
EPS Growth	4.71%	-2.25%	8.05%	30.85%	-33.33%	-24.54%	406.87%
Forward PE	-	-	-	-	-	57.68	11.38
No. Analysts	-	-	-	-	-	8	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.1B	1.8B
Avg	994.6M	1.3B
Low	826.1M	934.1M

Revenue Growth

Revenue Growth	2026	2027
High	49.9%	77.8%
Avg	30.6%	31.6%
Low	8.5%	-6.1%

EPS Forecast

EPS	2026	2027
High	1.50	4.20
Avg	0.62	3.14
Low	-0.91	2.46

EPS Growth

EPS Growth	2026	2027
High	83.1%	578.7%
Avg	-24.5%	406.9%
Low	-	297.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.